Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification

Inclusion Criteria: * Participants of both sexes, aged 18 years or more; * Participants presenting the diagnosis of cataract with indication for surgery by the phacoemulsification procedure; * Participants who undergo surgery in only 1 eye at a time; * Participants with intraocular pressure (IOP) ≤ 20 mmHg; * Signed consent. Exclusion Criteria: * Used non-steroidal anti-inflammatory drugs or topical steroids or systemic inhalers within 21 days prior to randomization of the clinical trial; * Performing the surgery for the second time, to correct the previous procedure or to change the lens; * Decompensated glaucoma or ocular hypertension with IOP above 21 mmHg; * Active ocular infectious diseases; * History hypersensitivity to the active ingredients used in the study; * Pregnancy or risk of pregnancy and lactating patients; * History alcohol abuse or illicit drug use; * Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants; * Participation in clinical trial in the year prior to this study.